Gas Cylinder Explosion Kills Researcher at Indian Laboratory
Ashley P. Taylor | Dec 7, 2018
Two professors have been arrested for negligence in connection with the blast.
ISTOCK, SEASTOCK
No Regulatory Exemption for Gene-Edited Products in EU
No Regulatory Exemption for Gene-Edited Products in EU
The European Court of Justice has decided that organisms made with precision techniques such as CRISPR will be subject to the same rules as transgenic plants or animals.
The European Court of Justice has decided that organisms made with precision techniques such as CRISPR will be subject to the same rules as transgenic plants or animals.
Chair of Chemical Safety Board to Step Down
Ashley Yeager | May 25, 2018
Vanessa Allen Sutherland will resign next month, leaving the agency with just three members of what should be a five-person board.
FDA Seeks to Block Two Unregulated Stem Cell Clinics
Jim Daley | May 11, 2018
Two patients became legally blind after receiving treatments at the facilities.
Vision Restored: The Latest Technologies to Improve Sight
Anna Azvolinsky | Apr 10, 2018
Cell implants, gene therapy, even optogenetics are making headway in clinical trials to treat various forms of blindness.
FDA Report on BPA’s Health Effects Raises Concerns
Ashley Yeager | Feb 28, 2018
The pre-peer review assessment finds the compound has “minimal effects,” but endocrinologists and others say key data have yet to come out.
Federal Ban Lifted on Studying Most Dangerous Pathogens
Kerry Grens | Dec 20, 2017
Only a few labs will earn funding for such “gain-of-function” research on SARS, MERS, and other deadly diseases.
Artificial Tissues Implanted Without Regulatory Approval, Investigation Reports
Ashley P. Taylor | Oct 3, 2017
Tissue recipients were treated as “guinea pigs,” says investigation leader.
Women Lose Vision After Stem Cell Treatment
Kerry Grens | Mar 17, 2017
The adipose-derived cells were injected into the patients’ eyes to treat age-related macular degeneration.
Opinion: Preparing for Potential Disasters
Larissa Paschyn | Jan 25, 2017
How to increase the resiliency of biotechnology organizations in the face of emergency risks